TTVR Early Feasibility Study
NCT: NCT04433065 · ACTIVE_NOT_RECRUITING
NCT IDNCT04433065
StatusACTIVE_NOT_RECRUITING
Start Date2020-10-20
Completion2031-08-26
SponsorMedtronic Cardiovascular (INDUSTRY)
First posted
Last updated
Brief Summary
The objective of this early feasibility study is to gain early clinical insight into the performance of the Intrepid transcatheter tricuspid valve replacement (TTVR) system intended for transfemoral access to deliver a self-expanding bioprosthetic valve within the tricuspid valve.
Frequently Asked Questions
What is TTVR Early Feasibility Study?
TTVR Early Feasibility Study is a clinical trial registered under NCT04433065. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT04433065?
The current status of NCT04433065 (TTVR Early Feasibility Study) is: ACTIVE_NOT_RECRUITING.
When did TTVR Early Feasibility Study start?
TTVR Early Feasibility Study started on 2020-10-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.